 The main objective of this study is to investigate the safety and clinical outcome of intracoronary infusion of autologous bone marrow cells in patients with myocardial infarction MI. We hypothesize that patients treated with stem cell therapy will have beneficial effects on left ventricular LV remodeling and functional regeneration after MI and successful primary percutaneous coronary intervention PCI in setting of prospective randomized controlled trial. 